• About
  • Advertise
  • Privacy & Policy
  • Contact
New National Star
Advertisement
  • Home
  • Breaking news
  • Business
  • Entertainment
  • World
  • Politics
    • Press Release
  • Government
    • Nigeria
    • Metro
    • Security And Defecnce
  • Sports
    • Football
  • Columns
    • Articles
    • Opinions
No Result
View All Result
  • Home
  • Breaking news
  • Business
  • Entertainment
  • World
  • Politics
    • Press Release
  • Government
    • Nigeria
    • Metro
    • Security And Defecnce
  • Sports
    • Football
  • Columns
    • Articles
    • Opinions
No Result
View All Result
New National Star
No Result
View All Result
Home News

WHO Trial Finds ‘Remdesivir’ Has Little Effect On COVID-19

New National Star by New National Star
October 16, 2020
in News
1
WHO Trial Finds ‘Remdesivir’ Has Little Effect On COVID-19

Two ampules of Ebola drug Remdesivir are pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Ulrich Perrey/Pool via REUTERS

The World Health Organisation (WHO) on Friday dashed hopes that the Ebola drug ‘Remdesivir’ and three other existing medications could be useful tools against COVID-19.

Trials with four drugs conducted among 11,000 patients in 30 countries “appeared to have little or no effect’’ on survival and on the progression of the disease among hospitalised patients, the WHO said in Geneva.

The UN Health agency’s Solidarity Trial involved Remdesivir, the HIV treatment lopinavir/ritonavir, the malaria drug hydroxychloroquine and Interferon, which was developed for multiple sclerosis.

The European Union had placed its bets on Remdesivir. The European Commission announced a contract this month to secure additional supplies of the antiviral drug for up to 500,000 patients.

Despite questions about its effectiveness, Remdesivir was the first drug to receive EU approval to treat severe cases of the disease caused by the novel coronavirus.

U.S President Donald Trump has received Remdesivir as well as the anti-inflammatory medication dexamethasone and other drugs following his recent novel coronavirus infection, according to his doctors.

Although ‘Dexamethasone’ was not included in the WHO trials, it was shown to reduce mortality among hospitalized COVID-19 patients in a British study.

 

Tags: COVID-19Ebola drugRemdesivirWHO trialsWorld Health Organisation
Previous Post

NNPC Staff Convicted For N1.8m Fraud

Next Post

Twitter Creates #EndSARS Emoji

New National Star

New National Star

It's not just the new. New National Star engages, informs and entertains the most influential minds. We shape Africa through our news coverage and analysis. Our tradition of journalistic excellence and unparalleled access, paired with cutting-edge engineering, make New National Star the trusted source for our audience.

Next Post
Twitter Creates #EndSARS Emoji

Twitter Creates #EndSARS Emoji

Comments 1

  1. Pingback: สล็อตวอเลท

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected test

  • 23.8k Followers
  • 99 Subscribers
Plugin Install : Widget Tab Post needs JNews - View Counter to be installed
  • Trending
  • Comments
  • Latest
Nigeria-China: FG explores new avenue for investment

Nigeria-China: FG explores new avenue for investment

September 27, 2023
Accreditation, re-accreditation of programmes by NBTE commences in Fed Poly Nasarawa

Accreditation, re-accreditation of programmes by NBTE commences in Fed Poly Nasarawa

September 27, 2023
FG donates 10 operational vehicles to MDAs under ACReSAL, harps on mandate delivery

FG donates 10 operational vehicles to MDAs under ACReSAL, harps on mandate delivery

September 27, 2023
Social Protection: Anambra, UNICEF meet stakeholders, identify poorest areas

Social Protection: Anambra, UNICEF meet stakeholders, identify poorest areas

September 27, 2023

Recent News

Nigeria-China: FG explores new avenue for investment

Nigeria-China: FG explores new avenue for investment

September 27, 2023
Accreditation, re-accreditation of programmes by NBTE commences in Fed Poly Nasarawa

Accreditation, re-accreditation of programmes by NBTE commences in Fed Poly Nasarawa

September 27, 2023
FG donates 10 operational vehicles to MDAs under ACReSAL, harps on mandate delivery

FG donates 10 operational vehicles to MDAs under ACReSAL, harps on mandate delivery

September 27, 2023
Social Protection: Anambra, UNICEF meet stakeholders, identify poorest areas

Social Protection: Anambra, UNICEF meet stakeholders, identify poorest areas

September 27, 2023
Currently Playing
New National Star

We Tell It The Way It Is

Follow Us

Browse by Category

  • Africa
  • Agric
  • Articles
  • Awards
  • Breaking news
  • Business
  • Columns
  • Culture
  • Defence
  • Diaspora
  • Economy
  • Editorial
  • Education
  • Energy
  • Entertainment
  • Features
  • Football
  • Gender
  • Government
  • Health
  • Interview
  • Judiciary
  • Metro
  • News
  • Nigeria
  • Opinions
  • Politics
  • Press Release
  • Religion
  • Security And Defecnce
  • Sports
  • Technology
  • Under the Neem Tree 🎄
  • Us Today
  • World

Recent News

Nigeria-China: FG explores new avenue for investment

Nigeria-China: FG explores new avenue for investment

September 27, 2023
Accreditation, re-accreditation of programmes by NBTE commences in Fed Poly Nasarawa

Accreditation, re-accreditation of programmes by NBTE commences in Fed Poly Nasarawa

September 27, 2023
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Breaking news
  • Business
  • Entertainment
  • World
  • Politics
    • Press Release
  • Government
    • Nigeria
    • Metro
    • Security And Defecnce
  • Sports
    • Football
  • Columns
    • Articles
    • Opinions

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.